These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 23125220)

  • 1. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
    Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
    Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.
    Huang S; Li X; Zhu H
    Med Sci Monit; 2016 Nov; 22():4330-4337. PubMed ID: 27840403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.
    Deng M; Ye Q; Qin Z; Zheng Y; He W; Tang H; Zhou Y; Xiong W; Zhou M; Li X; Yan Q; Ma J; Li G
    Tumour Biol; 2013 Jun; 34(3):1793-800. PubMed ID: 23479198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
    Song L; Chen L; Luan Q; Kong Q
    J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
    Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
    Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells.
    Sun XJ; Liu H; Zhang P; Zhang XD; Jiang ZW; Jiang CC
    Asian Pac J Cancer Prev; 2013; 14(9):5533-7. PubMed ID: 24175854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-205 promotes proliferation, migration and invasion of nasopharyngeal carcinoma cells by activation of AKT signalling.
    Mao Y; Wu S; Zhao R; Deng Q
    J Int Med Res; 2016 Apr; 44(2):231-40. PubMed ID: 26880795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop.
    Yang CF; Yang GD; Huang TJ; Li R; Chu QQ; Xu L; Wang MS; Cai MD; Zhong L; Wei HJ; Huang HB; Huang JL; Qian CN; Huang BJ
    Oncogene; 2016 Jun; 35(26):3419-31. PubMed ID: 26568302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
    Xiong B; Cheng Y; Ma L; Zhang C
    Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression.
    Yu BL; Peng XH; Zhao FP; Liu X; Lu J; Wang L; Li G; Chen HH; Li XP
    Int J Oncol; 2014 Apr; 44(4):1215-22. PubMed ID: 24481647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
    Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
    Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
    Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway.
    Hu W; Wang Y; Zhang Q; Luo Q; Huang N; Chen R; Tang X; Li X; Luo H
    Cell Signal; 2023 Oct; 110():110833. PubMed ID: 37543098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
    He Q; Ren X; Chen J; Li Y; Tang X; Wen X; Yang X; Zhang J; Wang Y; Ma J; Liu N
    Oncotarget; 2016 Jan; 7(3):3047-58. PubMed ID: 26655091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.